APOE4 - Risks and Risk Management
APOE4 - Risks and Risk Management
A Practical Guide
Forever Healthy Foundation gGmbH
Amalienbadstraße 41
D-76227 Karlsruhe, Germany
Version 2.2
July 27, 2020
Preface
This Practical Guide is part of Forever Healthy's "Maximizing Health" initiative that seeks to review the world's leading medical knowledge on various health-related topics and turn it into actionable information.
Section 1: Overview
Motivation
APOE is the gene responsible for coding Apolipoprotein E, a key player in our lipid metabolism. APOE comes in 3 significant variants: ε2, ε3 & ε4. Since humans carry two copies of the gene, there are six possible permutations: APOE 2/2, 2/3, 2/4, 3/3, 3/4 & 4/4. In Europe / USA, roughly 75% of people are APOE3/3, and the APOE3/4 or 4/4 variants are present in 20 - 25 %.
The ε4 variant is well known for its association with a significantly higher risk of Alzheimer's disease. Numerous other conditions have been linked to it including different forms of dementia, cardiovascular disease (CVD), and decreased longevity. There are several important implications for carriers of one or two copies of the ε4 variant, particularly concerning saturated fat and heavy metal detox.
Key Questions
This analysis seeks to answer the following questions:
Which risks are involved in carrying one or two ε4 alleles?
What are the potential risk mitigation strategies?
Who should be tested for APOE4?
Impatient readers may choose to skip directly to Section 4 for the summary of findings and tips on risk management.